Back to search

Article

Synergistic Electroceutical-Glucocorticoid Intervention Mitigates Dexamethasone-Induced Muscle Atrophy in Aging Skeletal Muscle

2026-03-13

Abstract excerpt

Dexamethasone (DEX), a synthetic glucocorticoid widely prescribed for allergic and inflammatory diseases, is known to induce adverse effects, particularly skeletal muscle atrophy. DEX-induced atrophy exacerbates sarcopenia and has a more pronounced impact on aged skeletal muscle than on young skeletal muscle. To address this unmet clinical need, we introduce an electroceutical approach that counteracts DEX-induced...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0291b694-d648-5c4b-aef2-345c283f7162
DOI
10.64898/2026.03.10.709862
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Synergistic Electroceutical-Glucocorticoid Intervention Mitigates Dexamethasone-Induced Muscle Atrophy in Aging Skeletal MuscleDOI 10.64898/2026.03.10.709862
Select a neighboring publication to make it the new centre.